Sage Therapeutics, Inc.

CIK 1597553 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Sage Therapeutics, Inc..

Recent SEC filings

FiledFormAccession number
Nov 14, 2025SCHEDULE 13G/A0001013594-25-001411
Aug 14, 2025SCHEDULE 13G/A0001013594-25-001009
Aug 11, 202515-12G0001104659-25-076215
Aug 1, 2025S-8 POS0001104659-25-073162
Aug 1, 2025S-8 POS0001104659-25-073169
Aug 1, 2025S-8 POS0001104659-25-073173
Aug 1, 2025S-8 POS0001104659-25-073168
Aug 1, 2025POSASR0001104659-25-073175
Aug 1, 2025POSASR0001104659-25-073177
Aug 1, 2025S-8 POS0001104659-25-073158
Aug 1, 2025POSASR0001104659-25-073176
Aug 1, 2025S-8 POS0001104659-25-073167
Aug 1, 2025S-8 POS0001104659-25-073170
Aug 1, 2025S-8 POS0001104659-25-073171
Aug 1, 2025S-8 POS0001104659-25-073160
Aug 1, 2025S-8 POS0001104659-25-073172
Aug 1, 2025S-8 POS0001104659-25-073165
Aug 1, 2025S-8 POS0001104659-25-073174
Aug 1, 2025POSASR0001104659-25-073178
Aug 1, 2025S-8 POS0001104659-25-073166
Aug 1, 2025S-8 POS0001104659-25-073164
Aug 1, 2025S-8 POS0001104659-25-073157
Jul 31, 202540000950170-25-100653
Jul 31, 202540000950170-25-100666
Jul 31, 202540000950170-25-100663